Table 2.
Plasma and testicular tissue ARV quantification data
| Patient ID | Drug | Plasma (ng/mL) | Testes (ng/mL) | Testes/plasma ratio |
|---|---|---|---|---|
| 7 | DRV | 2043.70 | 396.59 | 0.19 |
| RTV | 48.90 | 389.29 | 7.96 | |
| 12 | TFV | 61.70 | 44.71 | 0.72 |
| TFV-DP | — | 5.83 | — | |
| FTC | 214.40 | 251.79 | 1.17 | |
| FTC-TP | — | 691.63 | — | |
| 25 | 3TC | 207.80 | 147.10 | 0.71 |
| 3TC-TP | — | 174.69 | — | |
| EFV | 7448.90 | 1856.45 | 0.25 | |
| 31 | 3TC | 125.80 | 140.36 | 1.12 |
| 3TC-TP | — | 108.80 | — | |
| DRV | 2375.80 | 523.11 | 0.22 | |
| RTV | 236.00 | 683.82 | 2.90 | |
| 39 | TFV | 51.01 | 43.51 | 0.85 |
| TFV-DP | — | 13.94 | — | |
| 3TC | 136.70 | 21.34 | 0.16 | |
| 3TC-TP | — | 3227.47 | — | |
| ATV | 1300.20 | 1029.76 | 0.79 | |
| RTV | 271.80 | 523.81 | 1.93 |
DRV, darunavir; RTV, ritonavir; TFV, tenofovir; TFV-DP, tenofovir-diphosphate; FTC, emtricitabine; FTC-TP, emtricitabine-triphosphate; 3TC, lamivudine; 3TC-TP, lamivudine-triphosphate; EFV, efavirenz; ATV, atazanavir.